Results 231 to 240 of about 20,292 (247)

Cost-effectiveness of Statin Therapy for ASCVD—Reply

JAMA, 2015
Ankur, Pandya, Milton C, Weinstein, Thomas A, Gaziano   +2 more
openaire   +2 more sources

Depression and Atherosclerotic Cardiovascular Disease (ASCVD) Risk Estimator in Women

Advances in Experimental Medicine and Biology, 2023
Maria Polikandrioti, Ioannis Koutelekos, Evangelos Dousis   +2 more
exaly  

Associations Between Common Polymorphisms of CDKN2B-AS and Susceptibility to ASCVD

Angiology, 2020
Hongyan Jin, Guokang Yang
exaly  

Using Race with Caution in the ASCVD Calculator.

American family physician, 2021
Mara, Gordon, Isha Marina, Di Bartolo
openaire   +1 more source

Extreme Atherosclerotic Cardiovascular Disease (ASCVD) Risk Recognition

Current Diabetes Reports, 2019
exaly  

Elevated lipoprotein(a) increases risk of subsequent major adverse cardiovascular events (MACE) and coronary revascularisation in incident ASCVD patients: A cohort study from the UK Biobank

Atherosclerosis
Paul Welsh, Philippe Ferber
exaly  

Inflammatory and metabolic markers mediate the association of hepatic steatosis and fibrosis with 10-year ASCVD risk

Annals of Medicine
Xingying Chen, Genfeng Yu, Yuqi Jiang
exaly  

Performance of PREVENT and pooled cohort equations for predicting 10-Year ASCVD risk in the UK Biobank

American Journal of Preventive Cardiology
Matthew Ambrosio, Pamela L Alebna, Anurag Mehta   +2 more
exaly  

Coronary Artery Calcium Scoring in the Assessment of ASCVD Risk

Journal of Cardiopulmonary Rehabilitation and Prevention
Edward Yang, Charles A. German
openaire   +2 more sources

LDL Cholesterol The Silent Contributor to ASCVD

Indunil Karunarathna, Mud Abeyak
openaire   +1 more source